--York Water Raises Quarterly Dividend by 4% to $0.2192 a Share, Payable Jan. 15 to Shareholders Of Record on Dec. 31-March 2024-www.financetom.com

--York Water Raises Quarterly Dividend by 4% to $0.2192 a Share, Payable Jan. 15 to Shareholders Of Record on Dec. 31

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--York Water Raises Quarterly Dividend by 4% to $0.2192 a Share, Payable Jan. 15 to Shareholders Of Record on Dec. 31

Nov 26, 2024 11:21 AM

01:47 PM EST, 11/26/2024 (MT Newswires) --

Price: 35.90, Change: -0.17, Percent Change: -0.47

Previous page： Top Premarket Decliners Next page： Nano One Materials Widens 2023 Net Loss YOY

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Top Premarket Decliners

Mar 28, 2024

08:12 AM EDT, 03/28/2024 (MT Newswires) -- Gamida Cell ( GMDA ) shares tumbled 18% in recent Thursday premarket activity a day after reporting a larger-than-expected Q4 net loss per share. Strata Skin Sciences ( SSKN ) shares fell 15% a day after it reported a higher Q4 net loss per share and lower net revenue from a year earlier....

Nano One Materials Widens 2023 Net Loss YOY

Mar 28, 2024

08:11 AM EDT, 03/28/2024 (MT Newswires) -- Nano One Materials Corp. ( NNOMF ) said Thursday that its net loss in 2023 widened to $31.8 million, or a loss of $0.30 per share, from the 2022 net loss of $15.8 million, or a loss of $0.16 per share. The company's cash and cash equivalent position stood at $31.9 million at...

Theratechnologies To Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology Platform

Mar 28, 2024

08:10 AM EDT, 03/28/2024 (MT Newswires) -- Theratechnologies Inc. ( THTX ) on Thursday announced two posters will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, demonstrating the potential of its SORT1+ TechnologyTM platform - including novel camptothecin-peptide conjugates and its lead investigational peptide drug conjugate (PDC) candidate, sudocetaxel zendusortide (TH1902), as anticancer treatments. The...

EnCap Investments seeks sale of Utah oil producer XCL Resources, sources say

Mar 28, 2024

March 28 (Reuters) - EnCap Investments is seeking to sell XCL Resources, four people familiar with the matter said, two years after the private equity firm's plan to combine the oil and gas producer with a local rival was thwarted by U.S. antitrust regulators. XCL, one of the largest energy producers in the Uinta shale formation of Utah, could be...